Unprecedented national effort by UK immunologists to search for answers on COVID-19

A major new project, led by a University of Birmingham immunologist, is one of three new UK-wide studies bringing together scientists from 17 research institutions. It will receive a share of £8.4 million from UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR) to understand immune responses to the novel coronavirus. … Continue reading “Unprecedented national effort by UK immunologists to search for answers on COVID-19”

Community testing site opens at University of Birmingham

A walk-through coronavirus testing facility has opened today at BHP founder-member the University of Birmingham, as part of the Government’s UK-wide drive to improve the accessibility of coronavirus testing for communities.  Open to staff, students and the local community and situated in the Sports Centre car park at the Southgate entrance, the site will offer … Continue reading “Community testing site opens at University of Birmingham”

Breakthrough antibodies test to detect ‘hidden’ COVID-19 cases launches in Birmingham

A new test to detect COVID-19 antibodies in people with recent exposure, who are asymptomatic, or have mild symptoms has been launched by The Binding Site in collaboration with the Clinical Immunology Service at BHP founder-member the University of Birmingham. The unique SARS-CoV-2 Antibody ELISA has been developed to identify individuals who have had a mild, non-hospitalised … Continue reading “Breakthrough antibodies test to detect ‘hidden’ COVID-19 cases launches in Birmingham”

SARS-CoV-2 antibody ELISA test launched

In collaboration with scientists from across BHP, The Binding Site – a University of Birmingham spin-out – has released a quality IgG, IgA and IgM SARS-CoV-2 antibody ELISA test. Given the range of symptoms of coronavirus and the lack of distinguishing clinical features, understanding the infection prevalence is of key importance. Diagnostic tests for COVID-19 … Continue reading “SARS-CoV-2 antibody ELISA test launched”

Better drug treatment for miscarriage found, as patients struggle to access surgery in COVID-19 pandemic

A new drug combination is more effective for women having miscarriages without symptoms than current standard NHS treatment, according to an NIHR-funded study from the Tommy’s National Centre for Miscarriage Research, published today in The Lancet. Missed miscarriage (also known as delayed or silent miscarriage) is when a pregnancy has ended in the womb but the … Continue reading “Better drug treatment for miscarriage found, as patients struggle to access surgery in COVID-19 pandemic”